Actinium Pharmaceuticals, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Actinium Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Actinium Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $153K, a 2% increase year-over-year.
  • Actinium Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $606K, a 72.2% increase from 2022.
  • Actinium Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $352K, a 6.63% decline from 2021.
  • Actinium Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $377K, a 0.53% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $606K +$254K +72.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $352K -$25K -6.63% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $377K +$2K +0.53% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $375K +$19K +5.34% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
2019 $356K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.